Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.720
-0.110 (-6.01%)
At close: Mar 9, 2026, 4:00 PM EDT
1.689
-0.031 (-1.80%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Adial Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 6 | 7 | 2 | 6 | 57 | |
| Market Cap Growth | -61.61% | -10.34% | 188.66% | -60.76% | -89.79% | 131.15% | |
| Enterprise Value | -4 | 1 | 1 | 2 | 0 | 50 | |
| Last Close Price | 1.83 | 5.50 | 25.25 | 46.50 | 134.38 | 1687.50 | |
| PB Ratio | 0.39 | 1.11 | 1.61 | 0.56 | 1.76 | 16.12 | |
| P/TBV Ratio | 0.36 | 1.11 | 1.61 | 0.56 | 1.77 | 20.21 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.07 | |
| Net Debt / Equity Ratio | -1.11 | -1.11 | -0.92 | -0.69 | -1.22 | -1.65 | |
| Net Debt / EBITDA Ratio | 0.75 | 0.75 | 0.45 | 0.41 | 0.37 | 0.33 | |
| Net Debt / FCF Ratio | 0.91 | 0.91 | 0.54 | 0.42 | 0.36 | 0.48 | |
| Quick Ratio | 4.21 | 4.21 | 3.84 | 4.33 | 2.24 | 2.23 | |
| Current Ratio | 4.43 | 4.43 | 4.16 | 4.90 | 2.67 | 2.37 | |
| Return on Equity (ROE) | -170.73% | -170.73% | -323.80% | -190.27% | -318.27% | -518.38% | |
| Return on Assets (ROA) | -83.20% | -83.20% | -105.88% | -82.24% | -102.77% | -170.58% | |
| Return on Capital Employed (ROCE) | -147.80% | -147.80% | -203.60% | -168.70% | -275.50% | -372.30% | |
| Earnings Yield | -424.80% | -136.06% | -201.82% | -226.15% | -220.51% | -34.34% | |
| FCF Yield | -345.74% | -110.74% | -105.86% | -300.46% | -193.74% | -21.24% | |
| Buyback Yield / Dilution | -244.55% | -244.55% | -240.54% | -42.25% | -34.69% | -49.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.